Announcements Trials
Browse Landscape

Phase

Phase 2 7Phase 1/2 6Phase 1 2Phase 2/3 1

Status

Unknown 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1

Conditions

Glioblastoma 8Recurrence 3Astrocytoma 3Gliosarcoma 2Spinal Cord Neoplasms 1Small Cell Lung Carcinoma 1Pituitary Neoplasms 1Oligodendroglioma 1Non Small Cell Lung Cancer Metastatic 1Melanoma 1Medulloblastoma 1Glioma 1Ependymoma 1Brain Neoplasms 1Advanced Glioblastoma 1

Interventions

Topotecan 2Drug Therapy 2sintilimab 1dinutuximab 1atezolizumab 1Temozolomide 1SR 48692 1Rabeprazole 1Irinotecan 1Etoposide 1Electroporation 1EC regimen 1E-3810 1Cryosurgery 1Carboplatin 1Bevacizumab 12,2',4,4',5-pentachlorodiphenyl ether 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 2/3 × Small Cell Lung Carcinoma × Temozolomide × Clear all
NCT02772107 2016-05-17

Temozolomide as Maintenance Therapy Following Induction Chemotherapy in Extensive Stage Small Cell Lung Cancer

Chinese PLA General Hospital

Phase 2/3 Unknown
132 enrolled
Thoracic

Small Cell Lung Carcinoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡